Resolving cognitive heterogeneity in white matter hyperintensities through integrated analyses of microbiome, metabolome, and brain glymphatic function
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Xiaotao Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: White Matter, Metabolome, Cognitive Dysfunction, Glymphatic System. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Anhui Provincial Natural Science Foundation, Scientific Research Key Project of Anhui Province Universities.
Abstract (Originalsprache)
INTRODUCTION Individuals with similar white matter hyperintensities (WMH) burden show heterogeneous cognitive outcomes, yet the biological mechanisms underlying this variability remain incompletely understood. METHODS We integrated 16S rDNA sequencing, untargeted metabolomics, and multi‐modal magnetic resonance imaging (MRI) to comprehensively characterize gut microbiome, plasma metabolome, and brain glymphatic function in 56 healthy controls, 40 WMH with normal cognition (WMH‐NC), and 49 WMH with cognitive impairment (WMH‐CI). RESULTS Group comparisons revealed differences in six bacterial genera, three plasma metabolites, and five glymphatic markers across three groups, with Acetivibrio , 1,5‐naphthalenediamine, beta‐uridine, free water fraction within the white matter, and index of diffusivity along the perivascular spaces (ALPS index) showing differences between WMH‐CI and WMH‐NC. Correlation and mediation analyses demonstrated associations between microbiota and cognition, mediated by tetradecyldiethanolamine and ALPS index. DISCUSSION These findings provide preliminary insights into plausible microbiota‐metabolites‐glymphatic function‐cognition associations in WMH, potentially informing more targeted interventions for vascular cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Research Center of Clinical Medical Imaging, Anhui Province, Hefei, China.
- Anhui Provincial Key Laboratory for Brain Bank Construction and Resource Utilization, Hefei, China.
- Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Förderung
- National Natural Science Foundation of China
- Anhui Provincial Natural Science Foundation
- Scientific Research Key Project of Anhui Province Universities
- Scientific Research Foundation of Anhui Medical University
- Natural Science Foundation of Anhui Province
Zitieren
APA
Xu, X., Zhou, X., Zhang, M., Fang, J., Yan, Z., Zhu, X., Yu, Y., & Zhu, J. (2026). Resolving cognitive heterogeneity in white matter hyperintensities through integrated analyses of microbiome, metabolome, and brain glymphatic function. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71201
Vancouver
Xu X, Zhou X, Zhang M, Fang J, Yan Z, Zhu X, et al. Resolving cognitive heterogeneity in white matter hyperintensities through integrated analyses of microbiome, metabolome, and brain glymphatic function. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71201
BibTeX
@article{Xu2026,
author = {Xu, Xiaotao and Zhou, Xia and Zhang, Mengwei and Fang, Jingjing and Yan, Zhiqing and Zhu, Xiaoqun and Yu, Yongqiang and Zhu, Jiajia},
title = {Resolving cognitive heterogeneity in white matter hyperintensities through integrated analyses of microbiome, metabolome, and brain glymphatic function},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71201}
}
EUVIMED